Blood Transfusion Diagnostics Market Outlook:
Blood Transfusion Diagnostics Market size was over USD 5.35 Billion in 2025 and is projected to reach USD 9.67 Billion by 2035, witnessing around 6.1% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of blood transfusion diagnostics is evaluated at USD 5.64 Billion.
The market growth is primarily driven by a growing number of people with kidney malfunction. Kidney failure, commonly known as chronic kidney disease (CKD), is a disorder in which the kidneys are unable to adequately eliminate waste and excess fluids from the blood. This can result in a variety of problems, including anemia, which is frequent in CKD patients. Regular blood transfusions are frequently required for CKD patients to manage anemia, as well as other problems like hemorrhage, coagulation, and infection. Around 850 million people are suffering from some kind of kidney problem. Additionally, around 121,000 people in the United States need kidney transplantation.
Higher instances of injury and deaths caused by road accidents are to propel the growth of the global blood transfusion market. Road traffic accidents are a serious public health issue and a leading source of fatalities and injuries worldwide. These incidents frequently lead to serious injuries that need urgent medical attention and blood transfusions. The rising frequency of traffic accidents and related injuries is expected to boost the demand for blood. Approximately, 3,700 people die globally every day in vehicle crashes or being hit by a vehicle. Furthermore, the increased pressure of chronic disease in the world and the urgent requirement for blood donation due to the shortage of blood donations during the pandemic are the few factors expected to propel the market growth.
Key Blood Transfusion Diagnostics Market Insights Summary:
Regional Highlights:
- The North America blood transfusion diagnostics market will hold over 41% share by 2035, attributed to high accident rates and COVID-19 related blood supply disruptions.
- The Asia Pacific market will achieve substantial CAGR from 2026 to 2035, fueled by healthcare infrastructure and awareness of blood donation.
Segment Insights:
- The blood screening segment in the blood transfusion diagnostics market is projected to capture the largest share by 2035, driven by rising blood donations, transfusions, and increasing prevalence of infectious diseases like hepatitis B and HIV.
- The hospital-based laboratories segment in the blood transfusion diagnostics market is expected to sustain the highest market share by 2035, supported by better-equipped facilities, advanced technology, and increasing demand for diagnostic services in hospitals.
Key Growth Trends:
- Growing Prevalence of Chronic Disease
- Need to Fill the Blood Shortage Caused During Pandemic
Major Challenges:
- Shortage of Technologists to Perform Automated Autotransfusion
- Lack of appropriate Infrastructure
Key Players: Immucor, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Quotient Limited, Beckman Coulter, Inc., DiaSorin S.p.A., BD (Becton, Dickinson, and Company), Ortho Clinical Diagnostics, Grifols, S.A., Thermo Fisher Scientific Inc.
Global Blood Transfusion Diagnostics Market Forecast and Regional Outlook:
Market Size & Growth Projections:
- 2025 Market Size: USD 5.35 Billion
- 2026 Market Size: USD 5.64 Billion
- Projected Market Size: USD 9.67 Billion by 2035
- Growth Forecasts: 6.1% CAGR (2026-2035)
Key Regional Dynamics:
- Largest Region: North America (41% Share by 2035)
- Fastest Growing Region: Asia Pacific
- Dominating Countries: United States, China, Germany, Japan, United Kingdom
- Emerging Countries: China, India, Japan, South Korea, Thailand
Last updated on : 10 September, 2025
Blood Transfusion Diagnostics Market Growth Drivers and Challenges:
Growth Drivers
-
Higher Number of People in Need of Dialysis- Dialysis is a kidney failure treatment that filters the blood to remove unwanted toxins, waste products, and excess fluids. When the kidneys fail, the body may struggle to clean the blood and keep the system chemically balanced. This is estimated to boost the blood transfusion diagnostics market during the forecast period. Globally, approximately 5-10 million people need dialysis or transplantation. Moreover, the prevalence of chronic kidney disorder is nearly 10% in men and around 11% in women.
-
Growing Prevalence of Chronic Disease – Chronic diseases such as cancer, cardiovascular diseases, leukemia, and other autoimmune diseases may require a blood transfusion. According to the World Health Organization, chronic cardiovascular disease is the leading cause of death in the world. additionally, around 18 million people died of cardiovascular disease.
-
Need to Fill the Blood Shortage Caused During Pandemic - Blood shortages have been caused by COVID-19's impact on supply chains and blood donation networks. This is especially concerning during emergencies since operations and emergency medical treatment frequently require blood. The market for blood transfusion diagnostics may expand as a result of the growing need for diagnostic tools and tests to check for these diseases. During COVID-19, the activity of blood donation decreased by around 40% to 67%, which caused a huge shortage of blood in the entire world and the number of blood donors in various countries decreased by about 20-30%.
-
Increased Cases of Road Accidents – Road accidents often lead to urgent emergency room (ER) visits, which may require blood for transfusion immediately. By the report of the World Health Organization, around 1.3 million people, every day dies in road accidents.
Challenges
-
Shortage of Technologists to Perform Automated Autotransfusion - Advanced systems such as nucleic acid amplification test, and centrifugal machines used to separate blood cells requires skilled professionals, therefore, the lack of expert professionals is hampering the market growth.
-
Lack of appropriate Infrastructure
-
High Cost of Instruments, Tests & Treatment Required for Blood Transfusions
Blood Transfusion Diagnostics Market Size and Forecast:
| Report Attribute | Details |
|---|---|
|
Base Year |
2025 |
|
Forecast Period |
2026-2035 |
|
CAGR |
6.1% |
|
Base Year Market Size (2025) |
USD 5.35 Billion |
|
Forecast Year Market Size (2035) |
USD 9.67 Billion |
|
Regional Scope |
|
Blood Transfusion Diagnostics Market Segmentation:
Application
The blood transfusion diagnostics market is segmented and analyzed for demand and supply by application into blood group typing and blood screening. Out of the two, the blood screening segment is anticipated to hold the largest market size by the end of 2035. Rising blood donations and transfusions are likely to boost the growth of the segment. By the statistics of the WHO, about 119 million of blood is donated every year all around the world. In addition, the growing penetration of sexually transmitted diseases, hepatitis B, and HIV are driving the segment’s growth. According to the Centers for Disease Control and Prevention, around 296 million people are living with hepatitis B worldwide. Moreover, as per the World Health Organization, the prevalence of STDs has impacted more than 1 million people all over the world.
End-user
The global blood transfusion diagnostics market is also segmented and analyzed for demand and supply by end-user in hospital-based laboratories and blood banks. Out of these segments, hospital-based laboratories are projected to secure a higher market share by 2035. This can be owed to the fact that hospital-based laboratories are better equipped to conduct the complicated and crucial screening procedures necessary for blood transfusions since they are furnished with cutting-edge machinery and technology and operated by qualified personnel. Additionally, these labs are in a good position to provide patients with a variety of diagnostic services such as blood typing. Also, hospitals are expanding their diagnostic capabilities to satisfy the rising need for blood products as the demand for blood transfusions rises. For instance, it was found that there were about 6100 hospitals in the U.S. in 2022.
Our in-depth analysis of the global market includes the following segments:
|
By Product Type |
|
|
By Application |
|
|
By End-User |
|
Vishnu Nair
Head - Global Business DevelopmentCustomize this report to your requirements — connect with our consultant for personalized insights and options.
Blood Transfusion Diagnostics Market Regional Analysis:
North American Market Insights
North America industry is poised to account for largest revenue share of 41% by 2035. A higher number of road accidents taking place in the region is driving the market growth in North America. As of 2022, more than 6 million vehicle crashes took place in the United States. The growth is also attributed to the lack of blood during COVID-19, which in turn is propelling the requirement for blood donation. Since March 2020, the rate of blood donation dropped by about 10% and there has been about a 62% decrease in blood drives across colleges and schools.
APAC Market Insights
The Asia Pacific blood transfusion diagnostics market is projected to grow substantially till 2035. It is driven by aspects such as the rising need for blood transfusions, the developing healthcare infrastructure in the area, and the rising public awareness of the value of blood donation and testing. A considerable portion of the Asia Pacific blood transfusion diagnostics market is anticipated to increase in countries like China and India owing to their big populations and quickly growing healthcare infrastructure. Other countries in the area are also anticipated to develop as well due to factors such as the rise in hospital-based diagnostic labs and the desire for quick and precise blood tests.
Blood Transfusion Diagnostics Market Players:
- Immucor, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- Quotient Limited
- Beckman Coulter, Inc.
- DiaSorin S.p.A.
- BD (Becton, Dickinson, and Company)
- Ortho Clinical Diagnostics
- Grifols, S.A.
- Thermo Fisher Scientific Inc.
Recent Developments
-
Danaher Corporation announced the acquisition of Aldervon. Aldervon was the only operating company within Danaher’s Life Sciences segment.
-
Grifols S.A. announced the acquisition of Biotest to boost the development and innovation of its product portfolio, increasing the availability of plasma therapy for patients.
- Report ID: 4481
- Published Date: Sep 10, 2025
- Report Format: PDF, PPT
- Get detailed insights on specific segments/region
- Inquire about report customization for your industry
- Learn about our special pricing for startups
- Request a demo of the report’s key findings
- Understand the report’s forecasting methodology
- Inquire about post-purchase support and updates
- Ask About Company-Level Intelligence Additions
Have specific data needs or budget constraints?
Inquiry Before BuyingFrequently Asked Questions (FAQ)
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Connect with our Expert
Copyright @ 2025 Research Nester. All Rights Reserved.
